AVEO Oncology
AVEO
#7099
Rank
HK$4.05 B
Marketcap
HK$116.77
Share price
0.00%
Change (1 day)
170.86%
Change (1 year)

AVEO Oncology (AVEO) - Net assets

Net assets on the balance sheet as of September 2022 : HK$0.22 Billion

According to AVEO Oncology 's latest financial reports the company has HK$0.22 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AVEO Oncology - Net assets on balance sheet (from 2008 to 2022)

Net assets by year

Year Net assets Change
2021-12-31$HK$0.35 B30.73%
2020-12-31$HK$0.27 B136.64%
2019-12-31$HK$0.11 B-154.23%
2018-12-31$-HK$0.22 Billion-33.05%
2017-12-31$-HK$0.32 Billion2035.72%
2016-12-31$-HK$14.92 Million-111.17%
2015-12-31$HK$0.13 B-16.46%
2014-12-31$HK$0.15 B-70.53%
2013-12-31$HK$0.54 B-41.17%
2012-12-31$HK$0.92 B-46.9%
2011-12-31$HK$1.73 B210.86%
2010-12-31$HK$0.55 B-693.98%
2009-12-31$-HK$94.04 Million-90.54%
2008-12-31$-HK$1 Billion29.54%
2007-12-31$-HK$0.77 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Biogen
BIIB
HK$141.73 B 63,021.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$240.99 B 107,224.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
HK$1.72 B 668.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$144.79 B 64,382.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$185.66 B 82,586.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$74.88 B 33,247.20%๐Ÿ‡บ๐Ÿ‡ธ USA